Oxytocin spray and nicotine patches for Lyme brain fog: what the evidence says

What did @daphnunez actually say?

The creator is experimenting with oxytocin nasal spray and nicotine patches (7mg, cut in half) for cognitive symptoms she calls "Lyme brain." She believes oxytocin "gets suppressed" during Lyme disease and autoimmune conditions. She also mentions, with some reluctance, that alcohol seems to temporarily clear her brain fog. She's currently on antibiotics and plans to try a hyperbaric oxygen chamber she purchased for about $1,000.

To be fair, she's not making sweeping cure claims. She says she won't feel benefits "right away" and frames this as personal experimentation. That's more honest than most Lyme content on TikTok. She's actively asking her audience for additional tips, which reads as someone genuinely struggling rather than someone selling something.

Does the science back this up?

Partially, and it depends which claim you're looking at. The nicotine patch angle has more real scientific support than most people expect. The oxytocin-Lyme connection is speculative at best. The alcohol observation is real but explains itself in ways that aren't actually helpful.

On nicotine: there is legitimate preclinical and early clinical interest in low-dose nicotine for cognitive function. Nicotine acts on alpha-4 beta-2 nicotinic acetylcholine receptors involved in attention and working memory. A 2023 study by Newhouse et al. in Neurology found transdermal nicotine improved cognitive performance in older adults with mild cognitive impairment. Whether that translates to Lyme-associated neurocognitive impairment specifically is a different question, and no controlled trials have tested it in that population.

On oxytocin: the claim that Lyme suppresses oxytocin is not well-documented in the peer-reviewed literature. Some researchers have looked at oxytocin dysregulation in chronic inflammatory conditions broadly, but connecting this specifically to Borrelia infection involves a lot of inferential leaps. Oxytocin nasal spray does cross the blood-brain barrier to some degree, and small trials (Guastella et al., 2013, Psychoneuroendocrinology) have examined its effects on social cognition, but "Lyme brain" is not among the studied indications.

What did they get wrong (or right)?

The oxytocin-suppression-from-Lyme claim is where the evidence runs thin. There's no peer-reviewed data specifically showing Borrelia burgdorferi infection suppresses oxytocin production. She may be extrapolating from broader chronic illness and stress-related oxytocin research, which is plausible as a hypothesis but not established science. Stating it as though it's known physiology is misleading, even if unintentionally so.

The alcohol observation deserves a more careful read than she gives it. Alcohol is a GABA-A receptor agonist and temporarily reduces neuroinflammatory signaling in some pathways. In people with Lyme-associated neurological symptoms, this might create a brief subjective sense of mental clarity. But she's right to flag that she's on antibiotics and that drinking is not the answer. Mixing alcohol with certain antibiotics (particularly metronidazole or tinidazole) causes a disulfiram-like reaction. She doesn't name her antibiotics, so this can't be fully assessed, but it's a real safety concern worth flagging.

Credit where it's due: cutting the nicotine patch in half to reduce dose is a reasonable harm-reduction approach. The 3.5mg effective dose she's likely getting is closer to what some researchers suggest for cognitive effects without cardiovascular side effects.

What should you actually know?

Post-treatment Lyme disease syndrome (PTLDS) is real and genuinely poorly understood. The cognitive symptoms she's describing, memory gaps, variable mental clarity, fluctuating severity, are documented in peer-reviewed literature. A 2022 review by Rebman and Aucott in Frontiers in Medicine confirmed that a subset of patients treated for Lyme disease report persistent neuropsychiatric and cognitive symptoms that don't resolve with standard antibiotic courses.

What's not established is whether any of the interventions she's trying, oxytocin spray, nicotine patches, hyperbaric oxygen, directly address the underlying mechanisms of PTLDS. Hyperbaric oxygen has been studied in Lyme patients specifically: a 1998 RCT by Fife et al. in the Journal of Infectious Diseases found no significant benefit over sham treatment for persistent Lyme symptoms. More recent interest in hyperbaric oxygen for neurological conditions exists, but it's not a proven solution for this specific population.

Anyone considering oxytocin nasal spray should know it's a prescription compound in regulated markets. It is not an over-the-counter supplement. Using it without medical supervision means you're dosing a hormone with receptor activity in the brain without knowing your baseline levels or whether it's appropriate for your condition.

Bottom line

The nicotine patch use has the most defensible scientific rationale of anything discussed here, though it's still off-label for cognitive symptoms. The oxytocin-Lyme connection is hypothesis, not established fact. The alcohol observation is physiologically interesting but not a treatment strategy, particularly given antibiotic interactions. The hyperbaric chamber has weak evidence specifically for Lyme. This is someone experimenting their way through a condition medicine hasn't solved, which is understandable. But viewers should know what's evidence-based versus what's informed self-experimentation.